Discover the effect on timelines after the new Clinical Trials Regulation
In this white paper, you will gain insights into the impact of the CTR on timelines one year after this regulation was put into force.
What you'll find in our white paper
This white paper is supported by real data from the SGS Clinical Pharmacology Unit in Belgium. You will discover:
- Average approval times
- Key influencing factors
- Comparative analysis with global players
